ReviewOpen forum infectious diseases2025

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Anna Maria Geretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.